PROMETIC BIOTHERAPEUTICS LTD - CAMBRIDGE
Company Profile | Company Filings |
Overview
PROMETIC BIOTHERAPEUTICS LTD is a Private Limited Company from CAMBRIDGE UNITED KINGDOM and has the status: Dissolved - no longer trading.
PROMETIC BIOTHERAPEUTICS LTD was incorporated 12 years ago on 01/05/2012 and has the registered number: 08053268. The accounts status is SMALL.
PROMETIC BIOTHERAPEUTICS LTD was incorporated 12 years ago on 01/05/2012 and has the registered number: 08053268. The accounts status is SMALL.
PROMETIC BIOTHERAPEUTICS LTD - CAMBRIDGE
This company is listed in the following categories:
72110 - Research and experimental development on biotechnology
72110 - Research and experimental development on biotechnology
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
31 / 12 | 31/12/2021 |
Registered Office
PARK GROUND FLOOR UNIT 1 ICONIX PARK, LONDON ROAD
CAMBRIDGE
CB22 3EG
UNITED KINGDOM
This Company Originates in : United Kingdom
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
01/05/2022 | 15/05/2023 |
Map
UNITED KINGDOM
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
PATRICK SARTORE | Feb 1974 | Canadian | Director | 2012-05-01 | CURRENT |
BRUCE PHILIP PRITCHARD | Aug 1972 | Scottish | Director | 2012-05-01 | CURRENT |
MR. KENNETH GALBRAITH | Oct 1962 | Canadian | Director | 2019-04-23 | CURRENT |
DR SIMON GEOFFREY BEST | Aug 1956 | British | Director | 2018-12-19 UNTIL 2019-04-23 | RESIGNED |
PIERRE LAURIN | Mar 1960 | Canadian | Director | 2012-05-01 UNTIL 2018-12-19 | RESIGNED |
Persons with Significant Control
Name | Active from | Born | Address | Level of control |
---|---|---|---|---|
Liminal Biosciences Inc | 2016-04-06 | Laval Quebec | Ownership of shares 75 to 100 percent |
Free Reports Available
Report | Date Filed | Date of Report | Assets |
---|---|---|---|
Abbreviated Company Accounts - PROMETIC BIOTHERAPEUTICS LTD | 2015-01-24 | 31-05-2014 | £238,576 Cash £-119,953 equity |